Hello, folks, and how are you today? Once again, sunny skies are unfolding over the Pharmalot corporate campus this morning, making for a pleasant start. And of course, we are complementing our good fortune with a couple of cups of stimulation. Please join us. Meanwhile, as always, we are getting busy trying to strike some items off our to-do list and have a hunch you have the same idea in mind. So time to get started. Here are a few tidbits to help you along. Hope your day goes well...
Lundbeck Searching For Partner For Alzheimer's Drug (Bloomberg News)
Warner Chilcott Ends Talks With Possible Buyers (Financial News)
AstraZeneca And BTG Abandon Drug For Sepsis (London Evening Standard)
Did Ranbaxy Abandon Generic Provigil Launch? (Economic Times)
Achillion Hep C Drug Shows Promise In Mid-Stage Study (Reuters)
Agennix Lung Cancer Drug Fails Late-Stage Trial (Pharma Times)
Novartis To Remain In Horsham UK Location (West Sussex County Times)
Uganda Bans Indian Drug Supplier (New Vision)
EDITOR'S NOTE: Please check this post for updates during the day